ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
PIMCO Dynamic Credit Income Fund
20.47
0.0000
成交量:
- -
成交額:
- -
市值:
30.77億
市盈率:
4.73
高:
20.47
開:
20.47
低:
20.47
收:
20.47
資料載入中...
總覽
公司
新聞
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞
PCI-SIG公佈CopprLink線纜規範 適用於PCIe 5.0/6.0標準
PChome
·
2024-05-06
印度計劃壟斷市場,中國藥企加速研發!“減肥神藥”專利將過期,誰的機遇?
华尔街见闻
·
2024-04-12
健康巡迴:動脈清理術後的標準療法可能已經過時
Reuters
·
2024-04-10
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PCI"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PCI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCI\",,,,,undefined,":{"symbol":"PCI","market":"US","secType":"STK","nameCN":"PIMCO Dynamic Credit Income Fund","latestPrice":20.47,"timestamp":1688155200000,"preClose":20.47,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":150317409,"eps":4.327,"marketStatus":"盤前交易","change":0,"latestTime":"05-29 07:56:50 EDT","open":20.47,"high":20.47,"low":20.47,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.327,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1748525400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":20.47,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCI\",,,,,undefined,":{"symbol":"PCI","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":150317409,"dividePrice":0,"high":20.47,"amplitude":0,"preClose":20.47,"low":20.47,"week52Low":20.25,"pbRate":"--","week52High":23.45,"institutionHeld":0,"latestPrice":20.47,"eps":4.327,"divideRate":0,"volume":0,"delay":0,"ttmEps":4.327,"open":20.47,"prevYearClose":21.2},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PCI\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PCI\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2433646924","title":"PCI-SIG公佈CopprLink線纜規範 適用於PCIe 5.0/6.0標準","url":"https://stock-news.laohu8.com/highlight/detail?id=2433646924","media":"PChome","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2433646924?lang=zh_tw&edition=fundamental","pubTime":"2024-05-06 09:00","pubTimestamp":1714957216,"startTime":"0","endTime":"0","summary":"PCI-SIG终于发布了CopprLink内部和外部线缆规范,适用于PCIe 5.0和PCIe 6.0标准,提供了32/64 GT/s的信号传输速率,并利用了由SNIA维护的成熟行业标准连接器外形尺寸。去年11月,PCI-SIG在美国丹佛科罗拉多会议中心举行了SC23会议,向成员展示了PCIe技术演示和新的PCI快速线缆命名方案,强调了PCIe技术是高性能计算互连的首选。PCI-SIG表示,PCIe内部和外部线缆新命名方案为“CopprLink”,相关规范正在制定当中,将满足PCIe 5.0和PCIe 6.0标准的使用要求。","market":"hk","thumbnail":"https://k.sinaimg.cn/n/spider20240505/325/w720h405/20240505/0cbb-b010cea02436b82870331e63eec16509.png/w120h90l50t1982.jpg","type":0,"news_type":0,"thumbnails":["https://k.sinaimg.cn/n/spider20240505/325/w720h405/20240505/0cbb-b010cea02436b82870331e63eec16509.png/w120h90l50t1982.jpg"],"rights":{"source":"sina_tech","url":"https://tech.sina.cn/mobile/xp/2024-05-06/detail-inauexpp2952901.d.html?vt=4","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}.weibo_user{#sourceStyle#; margin-bottom: 0; display: inline-block;}.weibo_time{#sourceStyle#};","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .j_float_wbro, .j_article_wbreco","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.sina.cn/mobile/xp/2024-05-06/detail-inauexpp2952901.d.html?vt=4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_tech","symbols":["PCI","BK4200","SIG"],"gpt_icon":0},{"id":"2426210233","title":"印度計劃壟斷市場,中國藥企加速研發!“減肥神藥”專利將過期,誰的機遇?","url":"https://stock-news.laohu8.com/highlight/detail?id=2426210233","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2426210233?lang=zh_tw&edition=fundamental","pubTime":"2024-04-12 07:40","pubTimestamp":1712878828,"startTime":"0","endTime":"0","summary":"业内人士表示,畅销减肥药物的专利即将到期,面对如此大的市场空间,印度想要垄断是不可能的。","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/c082d352-3e93-4035-b9d3-a50f878535e1.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/c082d352-3e93-4035-b9d3-a50f878535e1.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3712547","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3712547","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["BK1574","01477","BK1191","PCI"],"gpt_icon":0},{"id":"2426812845","title":"健康巡迴:動脈清理術後的標準療法可能已經過時","url":"https://stock-news.laohu8.com/highlight/detail?id=2426812845","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2426812845?lang=zh_tw&edition=fundamental","pubTime":"2024-04-10 03:55","pubTimestamp":1712692543,"startTime":"0","endTime":"0","summary":"动脉疏通后的双重抗血小板疗法可能已经过时研究人员在一次大型医学会议上建议,接受支架手术以疏通堵塞的心脏动脉后,心脏病患者应服用阿斯利康 血液稀释剂布利林达一年,但一个月后应停止同时服用阿司匹林。目前,妇女必须在乳房切除术痊愈后才能接受为期六周的日常放射治疗。在基线肾功能正常或受损的人群中,TMAO水平升高也与肾功能下降速度加快有关。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCI"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PCI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-12-13","symbol":"PCI","reason":null,"defaultRemindTime":1639405800000,"announcedDate":"2021-11-22","type":"delisting","dateTimestamp":1639371600000},{"market":"US","date":"2021-12-07","symbol":"PCI","amount":0.174,"defaultRemindTime":1638887400000,"name":"PIMCO Dynamic Credit Income Fund","recordDate":"2021-12-14","payableDate":"2021-12-08","currency":"USD","type":"dividend","dateTimestamp":1638853200000},{"market":"US","date":"2021-11-10","symbol":"PCI","amount":0.174,"defaultRemindTime":1636554600000,"name":"PIMCO Dynamic Credit Income Fund","recordDate":"2021-12-01","payableDate":"2021-11-12","currency":"USD","type":"dividend","dateTimestamp":1636520400000},{"market":"US","date":"2021-10-08","symbol":"PCI","amount":0.174,"defaultRemindTime":1633699800000,"name":"PIMCO Dynamic Credit Income Fund","recordDate":"2021-11-01","payableDate":"2021-10-12","currency":"USD","type":"dividend","dateTimestamp":1633665600000},{"market":"US","date":"2021-09-10","symbol":"PCI","amount":0.174,"defaultRemindTime":1631280600000,"name":"PIMCO Dynamic Credit Income Fund","recordDate":"2021-10-01","payableDate":"2021-09-13","currency":"USD","type":"dividend","dateTimestamp":1631246400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PCI\",market:\"US\",,,undefined,":[{"executeDate":"2017-01-11","recordDate":"2017-01-13","paymentDate":"2017-02-01","value":0.164063,"currency":"USD"},{"executeDate":"2017-02-09","recordDate":"2017-02-13","paymentDate":"2017-03-01","value":0.164063,"currency":"USD"},{"executeDate":"2017-03-09","recordDate":"2017-03-13","paymentDate":"2017-04-03","value":0.164063,"currency":"USD"},{"executeDate":"2017-04-11","recordDate":"2017-04-13","paymentDate":"2017-05-01","value":0.164063,"currency":"USD"},{"executeDate":"2017-05-09","recordDate":"2017-05-11","paymentDate":"2017-06-01","value":0.164063,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PCI\",market:\"US\",delay:false,,,undefined,":{}}}